4-(Trifluoromethoxy)benzoyl acetonitrile, 97.0%, 5g

3-OXA-1,8-DIAZASPIRO[4.5]DECAN-2-ONE, 95.0%, 250mg

5-METHOXY-3-(PIPERIDIN-1-YLMETHYL)-1H-INDOLE, 95.0%, 250mg

tert-Butyl (S)-2-(cyanomethyl)piperazine-1-carboxylate, 98%, 5g

tert-Butyl 7-bromo-3,4-dihydroquinoline-1(2H)-carboxylate, 95.0%, 1g

(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]100mg

Ethyl 4,5-dimethyl-1H-pyrazole-3-carboxylate, 95.0%, 1g

3-Amino-7-hydroxy-2H-chromen-2-one, 95.0%, 1g

Ethylenediamine tetraacetic acid disodium salt dihydrate, 25 kg

1-(3,4-Dihydroxyphenyl)propan-1-one, 98%, 5g

C-Quinolin-6-yl-methylamine, 97.0%, 250mg

cis-Octahydroisoindole>97.0%(GC)(T)1g

2-(4-CHLOROPHENYL)-N-METHYLACETAMIDE, 95.0%, 1g